The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Phase 3 trial evaluating the efficacy and safety of odronextamab plus chemotherapy versus rituximab plus chemotherapy in previously untreated follicular lymphoma (OLYMPIA-2).
 
Colin Hardin
No Relationships to Disclose
 
Carl Gray
No Relationships to Disclose
 
Silvana Novelli
Consulting or Advisory Role - Mundipharma Research
Research Funding - Novartis
 
Tuba Hacibeki̇roglu
No Relationships to Disclose
 
Münci Yağcı
Consulting or Advisory Role - Abbvie
 
Ruemu Ejedafeta Birhiray
Consulting or Advisory Role - Abbvie; Array BioPharma; Epizyme; Ipsen; Janssen Biologics BV; Janssen Scientific Affairs; Lilly; REGENERON; Sanofi; Takeda; TG Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; BLUE MEDICINES; CTI; Daiichi Sankyo; DOVA/SOBI PHARMACEUTICALS; E.R. Squibb Sons, LLC; Exelixis; Genzyme; GLAXO ONCOLOGY; Incyte; Janssen Biotech; Lilly; MorphoSys; Pharmacyclics; Puma Biotechnology; Regeneron; Sanofi; Seagen; Stemline Therapeutics
 
Ashish Risal
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Manjusha Namuduri
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Jingxian Cai
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Melanie Ufkin
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Min Zhu
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Sushmita Mukherjee
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Jurriaan Brouwer-Visser
No Relationships to Disclose
 
Aafia Chaudhry
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Hesham Mohamed
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Odronextamab related patents
 
Srikanth R Ambati
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Elżbieta Iskierka-Jażdżewska
Honoraria - Abbvie; Amgen; BeiGene; Janssen; Novartis; Sandoz
Consulting or Advisory Role - Abbvie; Sandoz